Outset Medical Named a Winner in Round 2 of the KidneyX COVID-19 Kidney Care Challenge
Tablo Hemodialysis System recognized for its ease of use and remote-monitoring capabilities
The KidneyX COVID-19 Kidney Care Challenge recognizes solutions that reduce the transmission of the coronavirus among people with kidney diseases and/or reduce the risk of kidney damage among people who contract the virus. The challenge encouraged healthcare providers, staff, patients and caregivers on the front lines to share demonstrated solutions – particularly those implemented during the pandemic. With a total prize pool of
The pandemic brought about a critical need to reduce patient proximity during dialysis treatments to reduce transmission rates, and the Tablo Hemodialysis System introduced a technology-forward solution. Tablo incorporates sensors to track treatment, which are securely and wirelessly transmitted to the cloud. Through the TabloHubTM web interface, clinicians are able to remotely view treatment data in near real-time, reducing the risk of COVID-19 exposure while maintaining a high standard of care.
“In response to the pandemic, we incorporated feedback from clinicians to update the design of TabloHub to provide near real-time treatment data,” said Dr.
Outset Medical’s TabloHub enables physicians to remotely support and monitor this vulnerable patient population with live and historical data. Transforming TabloHub into a user-friendly, real-time display required minimizing data latency, leading to novel methods to transmit, display and interact with data. The platform enables clinicians to see a real-time view into patient treatment, with insight into patient data including pressures, alarms, ultrafiltration (UF), blood flow rate and remaining treatment time. This option supported flexible resource management during the COVID-19 staffing crisis, highlighted by the deployment of fifty Tablo Hemodialysis Systems to hospitals in
In addition to remote monitoring, Tablo also creates other efficiencies within the hospital. An all-in-one device with integrated water purification and on-demand dialysate production, Tablo eliminates the need for industrial water treatment rooms required to operate traditional hemodialysis machines. Tablo’s independence from this infrastructure enables bedside dialysis in the acute setting, saving the time and expense of transporting patients elsewhere for dialysis. With simplified operation through advanced software, sensor technology and a consumer-friendly touchscreen design, nurses are easily trained on Tablo within hours, expanding the level of staff who can treat patients on Tablo.
See the full list of winners here.
About
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of
About KidneyX
The Kidney Innovation Accelerator (KidneyX), a public-private partnership between the
KidneyX has already completed three competitions, awarding
For more information, visit kidneyx.org.
About the
The
About the
Since 1966, the
View source version on businesswire.com: https://www.businesswire.com/news/home/20210409005043/en/
Media Contact
Director,
nshannon@outsetmedical.com
Investor Contact
investors@outsetmedical.com
Source: